Overall, once-weekly semaglutide 1.0 mg as an add-on to basal insulin is the most efficacious GLP-1 receptor agonist in terms of reductions in HbA1c and body weight from baseline after 6 months of treatment.
Semaglutide Superior to Other GLP-1 Analogues as Add-On to Basal Insulin in T2D posted first on https://www.youtube.com/dailyhealthpost/
No comments:
Post a Comment